Rodríguez AC, de la Cruz ALE

Language: Spanish
References: 11
Page: 301-305
PDF size: 167.31 Kb.

ABSTRACT

Acquired long QT syndrome results from secondary causes and can be caused by more than 100 non-antiarrhythmic drugs. Cardiac arrest due to Torsades de pointes induced by drugs causing prolonged QT syndrome is a rare but potentially fatal event, even in hospitals. The case of a 47-year-old patient diagnosed with non-Hodgkin lymphoma admitted to the hematology department of the Dr. Gustavo Aldereguía Lima University General Hospital in Cienfuegos is presented. The patient had been previously treated with anthracyclines and developed episodes of palpitations and syncope later. The treatment included monitoring the patient, avoiding other QT prolonging agents and administrating magnesium sulfate and potassium chloride with a proper maintenance of the fluid and acid-base balance. The presentation of this case aims at motivating interest in new reports on the subject and establishing a direct causal relationship through the evidence provided by new experiences.

REFERENCES

1. Baró M, Sánchez EL, García W. Cardiotoxicidad por Antraciclinas. Presentación de un caso. MEDICIEGO. 2013 ; 19 Suppl 2: S1-7.

2. Geiger S, Lange V, Suhl P, Heinemann V, Stemmbler HJ. Anticancer therapy induced cardiotoxicity: review of the literature. Anticancer Drugs. 2010 ; 21 (6): 578-90.

3. López T, López P. Prevención y tratamiento de cardiotoxicidad en pacientes con cáncer. An Med (Mex). 2014 ; 59 (1): 54-60.

4. Plana JC. La quimioterapia y el corazón. Rev Esp Cardiol. 2011 ; 64 (5): 409-15.

5. Dubner SJ, Moss A, Pérez AR, Schapachnik E. El síndrome del intervalo QT prolongado desde el punto de vista de un cardiólogo. Rev Argent Cardiol. 2004 ; 72 (6): 467-73.

6. Viera B, De la Cruz LE. Mitoxantrone y síndrome QT prolongado adquirido. Presentación de un caso. Medisur [revista en Internet]. 2009 [ cited Jun 2014 ] ; 7 (2): [aprox. 4p]. Available f r o m : http://www.medisur.sld.cu/index.php/medisur/arti cle/view/620/95.

7. Navarrete EM, Zapata MM, Vera H, Erdmenger J, López B, Becerra R. Diagnóstico oportuno del daño al miocardio en pacientes tratados con antraciclinas: un reto para el siglo XXI. Bol Med Hosp Infant Mex. 2013 ; 70 (2): 72-7.

8. Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of Torsades de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010 ; 121 (8): 1047-60.

9. Contreras E, Gómez JE, Zuluaga SX. Síndrome de QT largo. Rev Colomb Cardiol. 2008 ; 15 (1): 12-7.

10. Borchert B, Lawrenz T, Stellbrink C. Long and short QT syndrome. Herzschrittmacherther Elektrophysiol. 2006 ; 17 (4): 205-10.

11. Alarcón L, Esper J, Álzate F, Insuasty JS. Cardiomiopatía inducida por antraciclinas en pacientes tratadas por cáncer de mama. MéD UIS. 2012 ; 25 (3): 264-1.